SEARCH

SEARCH BY CITATION

References

  • 1
    Miao RM, Fieldsteel AH. Genetics of Treponema: relationship between Treponema pallidum and five cultivable treponemes. J Bacteriol 1978; 133: 101.
  • 2
    Antal GM, Lukehart SA, Meheus AZ.The endemic treponematoses. Microbes Infect 2002; 4: 8394.
  • 3
    Centrurion-Lara A, Castro C, Castillo R, Shaffer JM, Van Voorhis WC, Lukehart SA. The flanking region sequences of the 15-kDa lipoprotein gene differentiate pathogenic treponemes. J Infect Dis 1998; 177: 10361040.
  • 4
    Eatough G. Fracastoro's Syphilis. Francis Cairns: Liverpool, 1984.
  • 5
    Rothschild BM, Calderon FL, Coppa A, Rothschild C. First European exposure to syphilis: the Dominican Republic at the time of Columbian contact. Clin Infect Dis 2000; 31: 936941.
  • 6
    Sparling PF. Natural history of syphilis. In Sexually Transmitted Diseases (3rd edn), HolmesKK, SparlingPF, MardhPA, et al (eds). McGraw-Hill: New York, 1999; 473478.
  • 7
    Gerbase A, Rowley JT, Mertens TE. Global epidemiology of sexually transmitted diseases. Lancet 1998; 351(Suppl III): 24.
  • 8
    Musher DM. Early syphilis. In Sexually Transmitted Diseases (3rd edn), HolmesKK, SparlingPF, MardhPA, et al (eds). McGraw-Hill: New York, 1999; 479485.
  • 9
    Stamm LV. Biology of Treponema pallidum. In Sexually Transmitted Diseases (3rd edn), HolmesKK, SparlingPF, MardhPA, et al (eds). McGraw-Hill: New York, 1999; 467472.
  • 10
    Singh AE, Romanowski B. Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 1999; 12: 187209.
  • 11
    Swartz MN, Healy BP, Musher DM. Late syphilis. In Sexually Transmitted Diseases (3rd edn), HolmesKK, SparlingPF, MardhPA, et al (eds). McGraw-Hill: New York, 1999; 487509.
  • 12
    Radolf JD, Sanchez PJ, Schulz KF, Murphy FK. Congenital syphilis. In Sexually Transmitted Diseases (3rd edn), HolmesKK, SparlingPF, MardhPA, et al (eds). McGraw-Hill: New York, 1999; 11651189.
  • 13
    World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. WHO: Geneva, WHO/HIV_AIDS/2001.02.
  • 14
    Tichonova L, Borisenko K, Ward H, Meheus A, Gromyko A, Renton A. Epidemics of syphilis in the Russian Federation: trends, origins, and priorities for control. Lancet 1997; 350: 210213.
  • 15
    Simms I, Fenton K, Ashton M, et al. The re-emergence of syphilis in the United Kingdom: the new epidemic phases. Sex Transm Dis 2005; 32: 220226.
  • 16
    Golden MR, Marra CM, Holmes KK. Update on syphilis: resurgence of an old problem. J Am Med Assoc 2003; 290: 15101514.
  • 17
    Centers for Disease Control and Prevention, National Center for HIV, STD, and TB Prevention. Sexually Transmitted Diseases Surveillance 2001; CDC: Atlanta, GA, September 2002.
  • 18
    Thomas DD, Navab M, Haake DA, Fogelman AM, Miller JN, Lovett MA. Treponema pallidum invades intercellular junctions of endothelium cell monolayers. Proc Natl Acad Sci U S A 1988; 85: 36083612.
  • 19
    Romanowski B, Sutherland R, Fick GH, Mooney D, Love EJ. Serologic response to treatment of infectious syphilis. Ann Internal Med 1991; 114: 10051009.
  • 20
    Clark EG, Danbolt N. The Oslo study of the natural course of untreated syphilis. An epidemiologic investigation based on a re-study of the Boeck–Bruusgaard material. Med Clin North Am 1964; 48: 613623.
  • 21
    Rockwell DH, Yobs AR, Moore MB. The Tuskegee study of untreated syphilis. The 30th year of observation. Arch Intern Med 1964; 114: 792798.
  • 22
    Roahn PD. Autopsy studies in syphilis. US Public Health Service, Venereal Disease Division. J Vener Dis Inf 1947; 21(Suppl).
  • 23
    Radolf JD, Norgard MV, Schulz WW. Outer membrane ultrastructure explains the limited antigenicity of virulent Treponema pallidum. Proc Natl Acad Sci U S A 1989; 86: 20512055.
  • 24
    Cox DL, Chang P, McDowell A, Radolf JD. The outer membrane, not a coat of host proteins, limits the antigenicity of virulent Treponema pallidum. Infect Immun 1992; 60: 10761083.
  • 25
    Salazar JC, Hazlett KR, Radolf JD. The immune response to infection with Treponema pallidum, the stealth pathogen. Microbes Infect 2002; 4: 11331140.
  • 26
    Blanco DR, Miller JN, Lovett MA. Surface antigens of the syphilis spirochete and their potential as virulence determinants. Emerg Infect Dis 1997; 3: 1120.
  • 27
    Centurion-Lara A, Castro C, Barrett L, et al. Major sheath protein homologue Tpr K is a target of opsonic antibody and the protective immune response. J Exp Med 1999; 189: 647656.
  • 28
    Morgan CA, Lukehart SA, Van Voorhis WC. Protection against syphilis correlates with specificity of antibodies to the variable regions of Treponema pallidum repeat protein K. Infect Immun 2003; 71: 56055612.
  • 29
    Leader BT, Hevner K, Molini BJ, Barrett LK, Van Voorhis WC, Lukehart SA. Antibody responses elicited against the Treponema pallidum repeat proteins differ during infection with different isolates of Treponema pallidum subsp. pallidum. Infect Immun 2003; 71: 60546057.
  • 30
    Centurion-Lara A, LaFond RE, Hevner K, et al. Gene conversion: a mechanism for generation of heterogeneity in the tprK gene of Treponema pallidum during infection. Mol Microbiol 2004; 52: 15791596.
  • 31
    Radolf JD. Role of outer membrane architecture in immune evasion by Treponema pallidum and Borrelia burgdorferi. Trends Microbiol 1994; 2: 307311.
  • 32
    Thomas DD, Baseman JB, Alderete JF. Putative Treponema pallidum cytadesins share a common functional domain. Infect Immun 1985; 49: 833835.
  • 33
    Blanco DR, Champion CI, Dooley A, et al. A monoclonal antibody that conveys in vitro killing and partial protection in experimental syphilis binds a phosphorylcholine surface epitope of Treponema pallidum. Infect Immun 2005; 73: 30833095.
  • 34
    Norris SJ. Polypeptides of Treponema pallidum: progress toward understanding their structural, functional, and immunologic roles. Treponema pallidum Polypeptide Research Group. Microbiol Rev 1993; 57: 750779.
  • 35
    Fraser CM, Norris SJ, Weinstock GM, et al. Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science 1998; 281: 375381.
  • 36
    Weinstock GM, Hardham JM, McLeod MP, Sodergren EJ, Norris SJ. The genome of Treponema pallidum: new light on the agent of syphilis. FEMS Microbiol Rev 1998; 22: 323332.
  • 37
    Radolf JD, Steiner B, Shevchenko D. Treponema pallidum: doing a remarkable job with what it's got. Trends Microbiol 1999; 7: 79.
  • 38
    Weinstock GM, Smajs D, Norris SJ. From microbial genome sequence to applications. Res Microbiol 2000; 151: 151158.
  • 39
    Pillay A, Liu H, Chan CY. Molecular subtyping of Treponema pallidum subspecies pallidum. Sex Transm Dis 1998; 8: 408414.
  • 40
    Norris SJ, Weinstock GM. The genome sequence of Treponema pallidum, the syphilis spirochete: will clinicians benefit? Curr Opin Infect Dis 2000; 13: 2936.
  • 41
    Magnuson HJ, Thomas EW, Olansky S, Kaplan BI, De Mello L, Cutler JC. Inoculation syphilis in human volunteers. Medicine 1965; 35: 3382.
  • 42
    Miller JN. Immunity in experimental syphilis. VI. Successful vaccination of rabbits with Treponema pallidum, Nichols strain, attenuated by γ-irradiation. J Immunol 1973; 110: 12061215.
  • 43
    Podwinska J, Lusiak M, Zaba R, Bowszyc J. The pattern and level of cytokines secreted by Th1 and Th2 lymphocytes of syphilitic patients correlate to the progression of the disease. FEMS Immunol Med Microbiol 2000; 28: 114.
  • 44
    Van Voorhis WC, Barrett LK, Koelle DM, Nasio JM, Plummer FA, Lukehart SA. Primary and secondary syphilis lesions contain mRNA for Th1 cytokines. J Infect Dis 1996; 173: 491495.
  • 45
    Fan YM, Zeng WJ, Wu ZH, Li SF. Immunophenotypes, apoptosis, and expression of Fas and Bcl-2 from peripheral blood lymphocytes in patients with secondary early syphilis. Sex Transm Dis 2004; 31: 221224.
  • 46
    Baker-Zander SA, Hook EW, Bonnin P, Handsfield HH, Lukehart SA. Antigens of Treponema pallidum recognized by IgG and IgM antibodies during syphilis in humans. J Infect Dis 1985; 151: 264272.
  • 47
    Gerber A, Krell S, Morenz J. Recombinant Treponema pallidum antigens in syphilis serology. Immunobiology 1996–1997; 196: 535549.
  • 48
    Radolf JD, Arndt LL, Akins DR, et al. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J Immunol 1995; 154: 28662877.
  • 49
    Brightbill HD, Libraty DH, Krutzik SR, et al. Host defence mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999; 285: 732736.
  • 50
    Berman SM. Maternal syphilis: pathophysiology and treatment. Bull W H O 2004; 82: 433438.
  • 51
    Genç M, Ledger WJ. Syphilis in pregnancy. Sex Transm Infect 2000; 76: 7379.
  • 52
    Michelow IC, Wendel GD, Norgard MV, et al. Central nervous system infection in congenital syphilis. N Engl J Med 2002; 346: 17921798.
  • 53
    Sheffield JS, Sánchez PJ, Wendel GD, et al. Placental histopathology of congenital syphilis. Obstet Gynecol 2002; 100: 126133.
  • 54
    Watson-Jones D, Changalucha J, Gumodoka B, et al. Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy. J Infect Dis 2002; 186: 940947.
  • 55
    Watson-Jones D, Oliff M, Terris-Prestholt F, et al. Antenatal screening in sub-Saharan Africa: lessons learned from Tanzania. Trop Med Int Health 2005; 10: 934943.
  • 56
    Gloyd S, Chai S, Mercer MA. Antenatal syphilis in sub-Saharan Africa: missed opportunities for mortality reduction. Health Policy Planning 2001; 16: 2934.
  • 57
    Schmid G. Economic and programmatic aspects of congenital syphilis prevention. Bull W H O 2004; 82: 402409.
  • 58
    Wicher V, Wicher K. Pathogensis of maternal–fetal syphilis revisited. Clin Infect Dis 2001; 33: 354363.
  • 59
    Fiumara NJ, Fleming WL, Downing JG, Good F. The incidence of prenatal syphilis at the Boston City Hospital. N Engl J Med 1951; 245: 634640.
  • 60
    Hollier LM, Harstad TW, Sanchez PJ, Twickler DM, Wendel GD. Fetal syphilis: clinical and laboratory characteristics. Obstet Gynecol 2001; 97: 947953.
  • 61
    Sánchez PJ, Wendel GD, Grimprel E, et al. Evaluation of molecular methodologies and rabbit infectivity testing for the diagnosis of congenital syphilis and neonatal central nervous system invasion by Treponema pallidum. J Infect Dis 1993; 167: 148157.
  • 62
    Watson-Jones D, Gumodoka B, Weiss H, et al. Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes. J Infect Dis 2002; 186: 948957.
  • 63
    Sheffield JS, Sánchez PJ, Morris G, et al. Congenital syphilis after maternal treatment for syphilis during pregnancy. Am J Obstet Gynecol 2002; 186: 569573.
  • 64
    Lynn WA, Lightman S. Syphilis and HIV: a dangerous combination. Lancet Infect Dis 2004; 4: 456466.
  • 65
    Erbelding E, Rompalo A. Changing epidemiology of syphilis and its persistent relationship with HIV. Curr Infect Dis Rep 2004; 6: 135140.
  • 66
    Poulton M, Curtis S, McElborough D, Williams DI, Fisher M. Syphilis: mimicking yet another disease! Sex Transm Infect 2001; 77: 325.
  • 67
    Buchacz K, Patel P, Taylor M, et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS 2004; 18: 20752079.
  • 68
    Rolfs RT, Josesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med 1997; 337: 307314.
  • 69
    Riedner G, Rusizoka M, Todd J, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 2005; 353: 12361244.
  • 70
    Wicher K, Horowitz HW, Wicher V. Laboratory methods of diagnosis of syphilis for the beginning of the third millennium. Microbes Infect 1999; 1: 10351049.
  • 71
    Van Voorhis WC, Barrett LK, Lukehart SA, Schmidt B, Schriefer M, Cameron CE. Serodiagnosis of syphilis: antibodies to recombinant Tp0453, Tp92, and Gpd proteins are sensitive and specific indicators of infection by Treponema pallidum. J Clin Microbiol 2003; 41: 36683674.